gabriella liszkay
National Institute of Oncology (NIO)
Budapest, Hungary
Review Editor
Cancer Molecular Targets and Therapeutics
National Institute of Oncology (NIO)
Budapest, Hungary
Review Editor
Cancer Molecular Targets and Therapeutics
Jiangsu University
Zhenjiang, China
Review Editor
Cancer Molecular Targets and Therapeutics
Nankai University
Tianjin, China
Review Editor
Cancer Molecular Targets and Therapeutics
Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University
Beijing, China
Review Editor
Cancer Molecular Targets and Therapeutics
Shandong University
Jinan, China
Review Editor
Cancer Molecular Targets and Therapeutics
West Virginia School of Osteopathic Medicine
Lewisburg, United States
Review Editor
Cancer Molecular Targets and Therapeutics
University of Kentucky
Lexington, United States
Review Editor
Cancer Molecular Targets and Therapeutics
University of Tennessee Health Science Center (UTHSC)
Memphis, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Université Clermont Auvergne
Clermont-Ferrand, France
Review Editor
Cancer Molecular Targets and Therapeutics
University of Bologna
Bologna, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
School of Medicine, Johns Hopkins University
Baltimore, United States
Review Editor
Cancer Molecular Targets and Therapeutics
National University of Quilmes
Bernal, Argentina
Review Editor
Cancer Molecular Targets and Therapeutics
Sir Run Run Shaw Hospital, School of Medicine, Graduate School, Zhejiang University
Hangzhou, China
Review Editor
Cancer Molecular Targets and Therapeutics
University of Cyprus
Nicosia, Cyprus
Review Editor
Cancer Molecular Targets and Therapeutics
Faculty of Pharmacy, University of Porto
Porto, Portugal
Review Editor
Cancer Molecular Targets and Therapeutics
University of Miami
Coral Gables, United States
Review Editor
Cancer Molecular Targets and Therapeutics